Continuous Glucose Monitoring in Type 2 Diabetes Patients with Basal-Only Insulin Regimens

CGM was associated with better glucose control, but the reason for that outcome is unclear.

Continuous glucose monitoring (CGM) improves glucose control in patients with type 2 diabetes who require intensive insulin regimens. In this multisite study, researchers explored the benefits of CGM in primary care patients who used less-intensive regimens with only basal insulin (1 or 2 doses of intermediate- or long-acting insulin daily without prandial insulin). One hundred seventy-five patients (mean age, 57; mean glycosylated hemoglobin [HbA_1c], 9.1%) were assigned randomly to use CGM or regular blood glucose meters (BGM). Blinded CGM assessments were collected from BGM patients for study purposes; CGM participants could take BGM readings as needed, and both groups had regular educational and counseling visits.

At 8 months, mean HbA_1c …

Reviewing Authors

Thomas L. Schwenk, MD

Disclosures

Editorial BoardsUpToDate

Thomas L. Schwenk, MD

Disclosures

Editorial BoardsUpToDate

Allan S. Brett, MD

Disclosures

Nothing to disclose

Allan S. Brett, MD

Disclosures

Nothing to disclose

Continuous Glucose Monitoring in Type 2 Diabetes Patients with Basal-Only Insulin Regimens

Topics

Reviewing Authors